Recent Finacing
Recent Raise
Holiferm develops and manufactures biosurfactants, operating a Wallasey sophorolipid plant (1.1 KTA, scaling to ~3.5 KTA then 15 KTA) and a Manchester R&D site piloting MELs and rhamnolipids.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Holiferm.
